AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Go back to AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call
(NASDAQ: ABCL) Delayed: 5.74 +0.21 (3.80%)
Previous Close $5.53    52 Week High
Open $5.57    52 Week Low
Day High $5.87    P/E N/A 
Day Low $5.58    EPS
Volume 5,499,877